Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option

Glioblastoma is one of the most difficult tumor types to manage, having high morbidity and mortality with available therapies (surgery, radiotherapy and chemotherapy). Immunotherapeutic agents like Oncolytic Viruses (OVs), Immune Checkpoint Inhibitors (ICIs), Chimeric Antigen Receptor (CAR) T cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Asija, Sweety, Chatterjee, Abhishek, Goda, Jayant S., Yadav, Sandhya, Chekuri, Godhanjali, Purwar, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050572/
https://www.ncbi.nlm.nih.gov/pubmed/37006286
http://dx.doi.org/10.3389/fimmu.2023.1118246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050572/
https://www.ncbi.nlm.nih.gov/pubmed/37006286
http://dx.doi.org/10.3389/fimmu.2023.1118246

Ejemplares similares